Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger.

Lee BY, Assi TM, Rajgopal J, Norman BA, Chen SI, Brown ST, Slayton RB, Kone S, Kenea H, Welling JS, Connor DL, Wateska AR, Jana A, Wiringa AE, Van Panhuis WG, Burke DS.

Am J Public Health. 2012 Feb;102(2):269-76. doi: 10.2105/AJPH.2011.300218. Epub 2011 Nov 28.

2.

Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand.

Lee BY, Assi TM, Rookkapan K, Wateska AR, Rajgopal J, Sornsrivichai V, Chen SI, Brown ST, Welling J, Norman BA, Connor DL, Bailey RR, Jana A, Van Panhuis WG, Burke DS.

PLoS One. 2011;6(9):e24673. doi: 10.1371/journal.pone.0024673. Epub 2011 Sep 13.

3.

A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.

Ngabo F, Levin A, Wang SA, Gatera M, Rugambwa C, Kayonga C, Donnen P, Lepage P, Hutubessy R.

Vaccine. 2015 Dec 16;33(51):7357-63. doi: 10.1016/j.vaccine.2015.10.022. Epub 2015 Oct 29.

4.
5.

Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.

Assi TM, Brown ST, Djibo A, Norman BA, Rajgopal J, Welling JS, Chen SI, Bailey RR, Kone S, Kenea H, Connor DL, Wateska AR, Jana A, Wisniewski SR, Van Panhuis WG, Burke DS, Lee BY.

BMC Public Health. 2011 Jun 2;11:425. doi: 10.1186/1471-2458-11-425.

6.

The impact of making vaccines thermostable in Niger's vaccine supply chain.

Lee BY, Cakouros BE, Assi TM, Connor DL, Welling J, Kone S, Djibo A, Wateska AR, Pierre L, Brown ST.

Vaccine. 2012 Aug 17;30(38):5637-43. doi: 10.1016/j.vaccine.2012.06.087. Epub 2012 Jul 10.

7.

Predictors of administration and attitudes about pneumococcal, Haemophilus influenzae type b and rotavirus vaccines among pediatricians in India: a national survey.

Gargano LM, Thacker N, Choudhury P, Weiss PS, Pazol K, Bahl S, Jafari HS, Arora M, Orenstein WA, Hughes JM, Omer SB.

Vaccine. 2012 May 21;30(24):3541-5. doi: 10.1016/j.vaccine.2012.03.064. Epub 2012 Apr 1.

PMID:
22475859
8.

Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.

Yang TU, Kim E, Park YJ, Kim D, Kwon YH, Shin JK, Park O.

Vaccine. 2016 Mar 18;34(13):1623-1629. doi: 10.1016/j.vaccine.2016.01.043. Epub 2016 Feb 3.

PMID:
26850759
9.

How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.

Mvundura M, Kien VD, Nga NT, Robertson J, Cuong NV, Tung HT, Hong DT, Levin C.

Vaccine. 2014 Feb 7;32(7):834-8. doi: 10.1016/j.vaccine.2013.12.029. Epub 2013 Dec 25.

PMID:
24370713
10.

Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.

Bar-Zeev N, Kapanda L, King C, Beard J, Phiri T, Mvula H, Crampin AC, Mwansambo C, Costello A, Parashar U, Tate JE, Verani JR, Whitney CG, Heyderman RS, Cunliffe NA, French N; VacSurv Consortium.

Vaccine. 2015 May 28;33(23):2637-45. doi: 10.1016/j.vaccine.2015.04.053. Epub 2015 Apr 24.

11.

Augmenting transport versus increasing cold storage to improve vaccine supply chains.

Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz MM, Paul P, Rajgopal J, Welling JS, Leonard J, Chen SI, Lee BY.

PLoS One. 2013 May 22;8(5):e64303. doi: 10.1371/journal.pone.0064303. Print 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/b428dad2-e829-4289-acae-c44369d55a80.

12.

Meeting the need for advocacy, social mobilisation and communication in the introduction of three new vaccines in South Africa - successes and challenges.

Baleta AF, van den Heever J, Burnett RJ.

Vaccine. 2012 Sep 7;30 Suppl 3:C66-71. doi: 10.1016/j.vaccine.2012.06.033. Review.

PMID:
22939025
13.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

PMID:
16088799
14.

Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain.

Pérez-Vilar S, Díez-Domingo J, López-Lacort M, Martínez-Úbeda S, Martinez-Beneito MA.

BMC Infect Dis. 2015 Feb 25;15:92. doi: 10.1186/s12879-015-0811-5.

15.

Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines.

De la Hoz-Restrepo F, Castañeda-Orjuela C, Paternina A, Alvis-Guzman N.

Vaccine. 2013 Jul 2;31 Suppl 3:C80-7. doi: 10.1016/j.vaccine.2013.05.064. Review.

PMID:
23777697
16.

Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.

Vučina VV, Filipović SK, Kožnjak N, Stamenić V, Clark AD, Mounaud B, Blau J, Hoestlandt C, Kaić B.

Vaccine. 2015 May 7;33 Suppl 1:A209-18. doi: 10.1016/j.vaccine.2014.12.043.

PMID:
25919163
17.

Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience.

Hull BP, Menzies R, Macartney K, McIntyre PB.

Vaccine. 2013 Apr 8;31(15):1964-9. doi: 10.1016/j.vaccine.2013.02.007. Epub 2013 Feb 17.

PMID:
23422140
18.

Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions.

Usuf E, Mackenzie G, Lowe-Jallow Y, Boye B, Atherly D, Suraratdecha C, Griffiths UK.

Vaccine. 2014 Apr 7;32(17):1975-81. doi: 10.1016/j.vaccine.2014.01.045. Epub 2014 Feb 3.

PMID:
24503271
19.

Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks.

Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz MM, Paul P, Rajgopal J, Welling JS, Leonard J, Claypool EG, Weng YT, Chen SI, Lee BY.

J Public Health Manag Pract. 2013 Sep-Oct;19 Suppl 2:S65-7. doi: 10.1097/PHH.0b013e31828a83fe.

20.

How influenza vaccination policy may affect vaccine logistics.

Assi TM, Rookkapan K, Rajgopal J, Sornsrivichai V, Brown ST, Welling JS, Norman BA, Connor DL, Chen SI, Slayton RB, Laosiritaworn Y, Wateska AR, Wisniewski SR, Lee BY.

Vaccine. 2012 Jun 22;30(30):4517-23. doi: 10.1016/j.vaccine.2012.04.041. Epub 2012 Apr 24.

Supplemental Content

Support Center